|
2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology
|
1U13CA206383-01
|
$10,000
|
$3,300
|
BEST, CAROLYN
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-02
|
$398,025
|
$398,025
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-12
|
$2,156,131
|
$2,156,131
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$31,913
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$11,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$15,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$181,360
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
4P01CA120964-10
|
$1,781,629
|
$142,530
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
3U24CA160034-05S1
|
$825,543
|
$206,386
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$208
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$600
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$1,184
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$48,955
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$25,830
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$181,519
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$1,265,093
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
|
1R01CA193675-01A1
|
$411,185
|
$411,185
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Novel Role of Honokiol in Preventing Cancer during Immune Suppression
|
5R21CA191735-02
|
$198,336
|
$198,336
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
THE ROLE OF LIN28B IN WILMS TUMOR
|
5F31CA186444-03
|
$35,896
|
$35,896
|
YERMALOVICH, ALENA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Regulation of MDSC function and trafficking
|
4R01CA168488-04
|
$376,829
|
$376,829
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Defining the functions and translational potential of ferroptosis
|
1R35CA209896-01
|
$809,277
|
$267,061
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$1,219
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$1,509
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$1,995
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$37,927
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-03
|
$1,106,869
|
$41,508
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer
|
5R21CA191687-02
|
$191,321
|
$191,321
|
CHOUEIRI, TONI
|
DANA-FARBER CANCER INST
|
|
New Paradigms for Targeting Truncal Driver Mutations
|
1R35CA210068-01
|
$982,500
|
$491,250
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
Misassembled BAF complexes in human cancer: structural and functional consequences
|
5F31CA196218-02
|
$29,237
|
$14,619
|
POYNTER, STEVEN
|
DANA-FARBER CANCER INST
|
|
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
|
1K99CA197640-01A1
|
$151,649
|
$151,649
|
WANG, XIAOFENG
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-03
|
$375,850
|
$18,793
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-03
|
$392,946
|
$9,824
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Extracellular Matrix and Cell Attachment Proteins
|
4R01CA047056-36
|
$311,168
|
$77,792
|
ERICKSON, HAROLD
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-03
|
$541,578
|
$27,079
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S1
|
$78,024
|
$780
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Kidney Cancer for this search: $41,837,803
|